We analyzed the expression levels of HIF1α, SLC16A3, SLC2A1, LDHA, CA9, and PDK1 in early (stages I–II) and advanced (stages IIIb–IV) NSCLC patients with low or high CD274 expression (Figure 2). The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.